Viewing nowRoxva Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

MFDS item code 201502366 · Approved 2015.04.17 · Insurance code 621802670
Inhibition of atherosclerosis progression by reducing hypercholesterolemia and the risk of cardiovascular disease
This medication is used in various situations associated with hypercholesterolemia. It is helpful for patients with primary hypercholesterolemia and mixed dyslipidemia who are not regulated by diet and exercise alone. It is also used in conjunction with dietary therapy in patients with familial hypercholesterolemia, and it can be applied especially for children and adolescents. It lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis, and is used as an adjunctive therapy in dietary management of patients with dysbetalipoproteinemia. Moreover, it is effective in reducing the risk of cardiovascular events such as stroke and myocardial infarction in middle-aged people at high risk for cardiovascular disease. Overall, this medication is used for improving blood cholesterol levels and preventing cardiovascular diseases.
For adult patients with primary hypercholesterolemia, this medication can be administered at any time without regard to meals. The initial dose is 5 milligrams once daily, and the maintenance dose is typically 10 milligrams once daily, with most patients regulated at this dosage. The maintenance dose should be adjusted according to LDL cholesterol levels, treatment goals, and patient response at intervals of 4 weeks or more, up to a maximum of 20 milligrams daily.
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17), the typical dosage range is 5 to 20 milligrams once daily. The dosing should be adjusted based on the individual therapeutic goals recommended for each patient.
This medication should not be used by patients who are allergic to specific components. Patients with active liver disease or significantly elevated liver enzymes should not take this medication. Patients with muscle disease or muscle problems should avoid this drug, and patients with certain autoimmune diseases should also exercise caution. Patients taking cyclosporine or those with severely impaired kidney function should preferably not use this medication. Women who are pregnant or breastfeeding, as well as fertile women not using appropriate contraception, should not take this medication, and women of childbearing age may use it only if they are fully aware of the risks of pregnancy and fetal hazards. Patients at high risk for muscle diseases, such as moderate renal impairment, hypothyroidism, genetic history of muscle disease, alcohol dependence, Asians, and patients receiving fibrate medications should avoid high doses. This medication contains lactose and should not be taken by patients with lactose intolerance or related genetic conditions. Patients with a history of liver disease or who consume alcohol excessively should undergo regular liver function tests, and those with hypothyroidism or nephrotic syndrome should take this medication only after treating the underlying conditions. Muscle-related symptoms such as myalgia or myopathy, and in severe cases, rhabdomyolysis, may occur, so if any muscle-related symptoms appear, the patient should immediately notify a physician and undergo testing. In particular, if muscle enzyme levels rise significantly, the medication should be discontinued, and re-administration at a lower dose may be considered once symptoms and levels return to normal. In acute severe conditions, the administration of this medication should be stopped, and it should not be used if symptoms of severe myasthenia gravis or ocular myasthenia gravis are present, as it may exacerbate these conditions. Caution is also needed, especially when used in combination with certain medications, as there may be a higher risk of muscle-related side effects, particularly with gemfibrozil. Kidney function tests may be necessary with high-dose use. Asian patients may have higher concentrations of the medication, so dosage adjustment may be required. In children and adolescents, the evaluation of effects on growth and development is limited, so caution is advised. This drug may cause mild side effects such as headache, dizziness, gastrointestinal discomfort, rash, myalgia, weakness, hematuria, diarrhea, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, decreased appetite, abdominal bloating, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, memory loss, peripheral neuropathy, cough, thrombocytopenia, increased transaminases, hepatitis, drug rash resembling lichen planus, lupus-like syndrome, muscle rupture, arthralgia, depression, sleep disturbances, and others. Rarely, severe liver damage, muscle diseases, severe skin reactions, and other abnormal symptoms may occur, so if any unusual symptoms appear, immediate consultation with healthcare personnel is essential. The medication should not be used during pregnancy or breastfeeding, and women planning pregnancy should use appropriate contraception. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme tests may be necessary. Caution is required when driving or operating machinery due to potential dizziness. This drug may interact with many other medications, so if taking other drugs, it is essential to consult with a physician or pharmacist. Particular caution is advised when used in combination with specific antiviral agents, immunosuppressants, antifungals, antibiotics, and fibrate medications.
Allergic reactions including urticaria and angioedema, chest tightness, difficulty breathing, severe rash with high fever, blisters, skin peeling, mucosal pain in mouth/eyes, jaundice, extreme fatigue, severe edemas, significantly reduced urine output, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, Stevens-Johnson syndrome, eosinophilia and systemic symptom drug reaction syndrome,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is recommended to keep it at room temperature between 1°C and 30°C. Storing it this way will maintain the effectiveness and safety of the medication.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.